ECSP055703A - POLIMORFO NOVEDOSO DEL N-METIL-N-(3-{3-[2-TIENILCARBONIL]-PIRAZOL-[1,5-a]-PIRIMIDINA-7-YL}FENIL)ACETAMIDA Y COMPUESTOS Y METODOS RELACIONADOS - Google Patents

POLIMORFO NOVEDOSO DEL N-METIL-N-(3-{3-[2-TIENILCARBONIL]-PIRAZOL-[1,5-a]-PIRIMIDINA-7-YL}FENIL)ACETAMIDA Y COMPUESTOS Y METODOS RELACIONADOS

Info

Publication number
ECSP055703A
ECSP055703A EC2005005703A ECSP055703A ECSP055703A EC SP055703 A ECSP055703 A EC SP055703A EC 2005005703 A EC2005005703 A EC 2005005703A EC SP055703 A ECSP055703 A EC SP055703A EC SP055703 A ECSP055703 A EC SP055703A
Authority
EC
Ecuador
Prior art keywords
acetamide
phenyl
methyl
methods
related compounds
Prior art date
Application number
EC2005005703A
Other languages
English (en)
Inventor
Scott E Zook
Donald Hettinger
Henry R Dubois Iii
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Publication of ECSP055703A publication Critical patent/ECSP055703A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)

Abstract

Polimorfo Forma III del N-metil-N-(3-{3-[2-tienilcarbonil]-pirazol-[1,5-a]-pirimidina-7-yl}fenil)acetamida, y su uso como sedante-hipnótico, ansiolítico, anticonvulsivante, y/o agente relajante de los músculos asociados al esqueleto. También se divulgan compuestos relacionados y métodos, particularmente en cuanto al tratamiento del insomnio.
EC2005005703A 2002-08-26 2005-03-23 POLIMORFO NOVEDOSO DEL N-METIL-N-(3-{3-[2-TIENILCARBONIL]-PIRAZOL-[1,5-a]-PIRIMIDINA-7-YL}FENIL)ACETAMIDA Y COMPUESTOS Y METODOS RELACIONADOS ECSP055703A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40607202P 2002-08-26 2002-08-26

Publications (1)

Publication Number Publication Date
ECSP055703A true ECSP055703A (es) 2005-05-30

Family

ID=31946959

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005005703A ECSP055703A (es) 2002-08-26 2005-03-23 POLIMORFO NOVEDOSO DEL N-METIL-N-(3-{3-[2-TIENILCARBONIL]-PIRAZOL-[1,5-a]-PIRIMIDINA-7-YL}FENIL)ACETAMIDA Y COMPUESTOS Y METODOS RELACIONADOS

Country Status (31)

Country Link
US (2) US6903106B2 (es)
EP (1) EP1532152B1 (es)
JP (2) JP4522859B2 (es)
KR (1) KR101063033B1 (es)
CN (1) CN1319974C (es)
AP (1) AP2005003220A0 (es)
AR (1) AR044191A1 (es)
AT (1) ATE343581T1 (es)
AU (1) AU2003268212B2 (es)
BR (1) BR0313695A (es)
CA (1) CA2493359C (es)
DE (1) DE60309332T2 (es)
DK (1) DK1532152T3 (es)
EA (1) EA200500421A1 (es)
EC (1) ECSP055703A (es)
ES (1) ES2274260T3 (es)
HR (1) HRP20050288A2 (es)
IL (2) IL166621A0 (es)
IS (1) IS7769A (es)
MA (1) MA27519A1 (es)
MX (1) MXPA05002251A (es)
NO (1) NO20050615L (es)
NZ (1) NZ538027A (es)
OA (1) OA12917A (es)
PE (1) PE20040979A1 (es)
PL (1) PL374436A1 (es)
PT (1) PT1532152E (es)
TN (1) TNSN05058A1 (es)
TW (1) TWI288135B (es)
WO (1) WO2004018476A1 (es)
ZA (1) ZA200501125B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL166621A0 (en) * 2002-08-26 2006-01-15 Neurocrine Biosciences Inc Polymorph of n-methyl-n-(3-ä-3-Ä2-thienylcarbonylÜ-pyrazol-Ä1,5-alphaÜpyrimidin-7-ylüacetamide and pharmaceutical compositions containing the same
US7429596B2 (en) * 2003-06-20 2008-09-30 The Regents Of The University Of California 1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
US7304069B2 (en) 2004-10-18 2007-12-04 Neurocrine Biosciences, Inc. Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5α]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related thereto
CN100528875C (zh) * 2005-02-18 2009-08-19 美德（江西）生物科技有限公司 无结晶型态的印地普隆及其制备方法
EP1918290A1 (en) 2006-10-11 2008-05-07 Ferrer Internacional, S.A. Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
EP1956021A1 (en) * 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
CN102180879B (zh) * 2006-11-09 2013-05-01 中国人民解放军军事医学科学院放射与辐射医学研究所 一种催眠药的多晶型α的乙酸溶剂化物
CN101177427B (zh) * 2006-11-09 2011-07-20 中国人民解放军军事医学科学院放射与辐射医学研究所 一种用于催眠的化合物的多晶型α和溶剂化物,其制备方法及含该物质的组合物
AT507187B1 (de) 2008-10-23 2010-03-15 Helmut Dr Buchberger Inhalator
CN102834987B (zh) 2010-03-25 2015-04-15 矢崎总业株式会社 接头连接器和用于识别接头连接器中的汇流条图案的方法
DK2377830T3 (en) * 2010-04-16 2016-07-18 Ivoclar Vivadent Ag Lithium silicate glass ceramics and glass with transition metal.
AT510837B1 (de) 2011-07-27 2012-07-15 Helmut Dr Buchberger Inhalatorkomponente
JP5681819B2 (ja) 2011-02-11 2015-03-11 バットマーク・リミテッド 吸入器コンポーネント
CN102174048B (zh) * 2011-03-08 2014-09-17 中国人民解放军军事医学科学院放射与辐射医学研究所 一种催眠药的新多晶型β
CA2839099C (en) 2011-09-06 2016-06-28 British American Tobacco (Investments) Limited Heating smokeable material
GB201207039D0 (en) 2012-04-23 2012-06-06 British American Tobacco Co Heating smokeable material
GB2533135B (en) 2014-12-11 2020-11-11 Nicoventures Holdings Ltd Aerosol provision systems
GB201511349D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic aerosol provision systems
GB201511361D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic vapour provision system
US20170055584A1 (en) 2015-08-31 2017-03-02 British American Tobacco (Investments) Limited Article for use with apparatus for heating smokable material
US11924930B2 (en) 2015-08-31 2024-03-05 Nicoventures Trading Limited Article for use with apparatus for heating smokable material
GB2542838B (en) 2015-10-01 2022-01-12 Nicoventures Trading Ltd Aerosol provision system
US20170119046A1 (en) 2015-10-30 2017-05-04 British American Tobacco (Investments) Limited Apparatus for Heating Smokable Material
MY192211A (en) 2016-04-27 2022-08-08 Nicoventures Trading Ltd Electronic aerosol provision system and vaporizer therefor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
US6472528B1 (en) 1999-08-10 2002-10-29 Neurocrine Biosciences, Inc. Synthesis of substituted pyrazolopyrimidines
US6485746B1 (en) 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
CN1331865C (zh) * 1999-09-02 2007-08-15 纽罗克里恩生物科学有限公司 多晶型物和含有该物质的组合物及相关的制备方法
US6384221B1 (en) * 1999-09-02 2002-05-07 Neurocrine Biosciences, Inc. Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
JP2001177971A (ja) * 1999-12-20 2001-06-29 Auto Network Gijutsu Kenkyusho:Kk 回転接続装置
IL166621A0 (en) * 2002-08-26 2006-01-15 Neurocrine Biosciences Inc Polymorph of n-methyl-n-(3-ä-3-Ä2-thienylcarbonylÜ-pyrazol-Ä1,5-alphaÜpyrimidin-7-ylüacetamide and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
JP2010070561A (ja) 2010-04-02
DK1532152T3 (da) 2007-02-26
CA2493359C (en) 2009-10-27
AP2005003220A0 (en) 2005-03-31
US7459458B2 (en) 2008-12-02
EA200500421A1 (ru) 2005-08-25
CN1319974C (zh) 2007-06-06
KR20050059082A (ko) 2005-06-17
WO2004018476A1 (en) 2004-03-04
TWI288135B (en) 2007-10-11
AU2003268212B2 (en) 2008-08-14
IL166621A (en) 2012-02-29
KR101063033B1 (ko) 2011-09-07
PT1532152E (pt) 2007-02-28
US20040116446A1 (en) 2004-06-17
CA2493359A1 (en) 2004-03-04
BR0313695A (pt) 2005-06-21
ZA200501125B (en) 2006-07-26
EP1532152A1 (en) 2005-05-25
OA12917A (en) 2006-10-13
PL374436A1 (en) 2005-10-17
NZ538027A (en) 2007-08-31
JP4522859B2 (ja) 2010-08-11
IL166621A0 (en) 2006-01-15
JP2005538149A (ja) 2005-12-15
ES2274260T3 (es) 2007-05-16
MA27519A1 (fr) 2005-09-01
NO20050615L (no) 2005-03-22
PE20040979A1 (es) 2005-01-07
DE60309332T2 (de) 2007-05-24
AR044191A1 (es) 2005-09-07
HK1071373A1 (en) 2005-07-15
IS7769A (is) 2005-03-23
TW200406404A (en) 2004-05-01
US6903106B2 (en) 2005-06-07
TNSN05058A1 (en) 2007-05-14
CN1678614A (zh) 2005-10-05
HRP20050288A2 (en) 2006-10-31
ATE343581T1 (de) 2006-11-15
US20050153988A1 (en) 2005-07-14
MXPA05002251A (es) 2005-06-08
EP1532152B1 (en) 2006-10-25
AU2003268212A1 (en) 2004-03-11
DE60309332D1 (de) 2006-12-07

Similar Documents

Publication Publication Date Title
ECSP055703A (es) POLIMORFO NOVEDOSO DEL N-METIL-N-(3-{3-[2-TIENILCARBONIL]-PIRAZOL-[1,5-a]-PIRIMIDINA-7-YL}FENIL)ACETAMIDA Y COMPUESTOS Y METODOS RELACIONADOS
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
CR7042A (es) Indanil aminas aciladas y su uso como farmacos
DK1689751T3 (da) 5,7-diaminpyrazolo[4,3-D]pyrimidiner med PDE-5-inhiberende aktivitet
TR200200408T2 (tr) Yeni spiro bileşikleri
UY28513A1 (es) Nuevos compuestos
UY28150A1 (es) Agentes terapeuticos
TW200621256A (en) Formulations
NO20055383D0 (no) Fremgangsmate for fremstilling av 1,3-propandiol
DE602006008641D1 (de) Herstellung und anwendung von tetrahydropyrrolo ä3, 2-cüpyridin-4-onderivaten zur behandlung von obesitas und psychiatrischen und neurologischen erkrankungen
MX2010002295A (es) Formas solidas que comprenden n-(5-ter-butil-isoxazol-3-il)-n´-{4- [7-(2-morfolin-4-il-etoxi) imidazo [2,1-b]-[1,3] benzotiazol-2-il] fenil} urea, composiciones de las mismas, y usos de las mismas.
CL2004000964A1 (es) Uso de compuestos derivados de piperazina 1,4 disustituida, util en el tratamiento de trastornos delusorios, psicosis y trastornos depresivos.
TW200619221A (en) Fused tricyclic derivatives
PT1344768E (pt) Sintese de pirazolpirimidinas substituidas
DE60319626D1 (de) Feuchtmittelversorgungsapparat vom Spraytyp
ECSP044971A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson
MY136822A (en) Derivatives of [6, 7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide and their use as inhibitors upon the interaction of cams and leukointegrins
DE112004002046D2 (de) Verfahren zum Herstellen von Hohlkörpern, Hohlkörper und Verwendung des Hohlkörpers
DK1742950T3 (da) Pyrazolo-[4,3-D]-pyrimidiner
HRP20090513T1 (hr) S-mirtazapin, namijenjen liječenju napadaja vrućine
UY27955A1 (es) Polimorfo novedoso del n-metil-n-(3-(3-(2- tienilcarbonil) - pirazol- (1,5-o)- pirimidina =7-yl)fenil) acetamida y compuestos y metodos relacionados
CY1110757T1 (el) Πυραζολο-[1,5-α]πυριμιδινες, διεργασιες, χρησεις και συνθeσεις
CR7712A (es) POLIMORFO NOVEDOSO DEL N-METIL-N-(3-(3-[2-TIENILCARBONIL]-PIRAZOL-[1,5a]-PIRIMIDINA-7-YL{FENIL)ACETAMIDA Y COMPUESTOS Y METODOS RELACIONADOS
DE602004031232D1 (de) Bohr-/walzverfahren bei der herstellung von nahtlosen rohren
AR043143A1 (es) Variedad cristalina de hemi-citrato de sildenafilo hidratado y su uso como agente terapeutico